| 1 |
2023 |
Massoud Houshmand, Vahide Zeinali, Amirhossein Hosseini, Atena Seifi, Bardia Danaei, Sharareh Kamfar. Investigation of FGF21 mRNA levels and relative mitochondrial DNA copy number levels and their relation in nonalcoholic fatty liver disease: a case-control study, Frontiers in Molecular Biosciences. 2023; 10: 1203019.
https://doi.org/10.3389/fmolb.2023.1203019 |
| 2 |
2024 |
Alfredo Caturano, Erica Vetrano, Raffaele Galiero, Celestino Sardu, Luca Rinaldi, Vincenzo Russo, Marcellino Monda, Raffaele Marfella, Ferdinando Carlo Sasso. Advances in the Insulin–Heart Axis: Current Therapies and Future Directions, International Journal of Molecular Sciences. 2024; 25: 10173.
https://doi.org/10.3390/ijms251810173 |
| 3 |
2023 |
Daria Shunkina, Anastasia Dakhnevich, Egor Shunkin, Olga Khaziakhmatova, Valeria Shupletsova, Maria Vulf, Alexandra Komar, Elena Kirienkova, Larisa Litvinova. gp130 Activates Mitochondrial Dynamics for Hepatocyte Survival in a Model of Steatohepatitis, Biomedicines. 2023; 11: 396.
https://doi.org/10.3390/biomedicines11020396 |
| 4 |
2022 |
Xiaojuan Wu, Ying Wang, Yumei Jia, Jia Liu, Guang Wang, Ferdinando Carlo Sasso. Risk Factors for Nonalcoholic Fatty Liver Disease with Different Insulin Resistance in a Nonobese Chinese Population, Journal of Diabetes Research. 2022; 2022: 1.
https://doi.org/10.1155/2022/9060405 |
| 5 |
2023 |
Georgia Anastasiou, Evangelos Liberopoulos, Ermioni Petkou, Amalia Despoina Koutsogianni, Petros Spyridwnas Adamidis, George Liamis, Evangelia Ntzani, Fotios Barkas. Association of Fatty Liver Index with Incident Diabetes Risk in Patients Initiating Statin–Therapy: A 6-Year Retrospective Study, Diagnostics. 2023; 13: 503.
https://doi.org/10.3390/diagnostics13030503 |
| 6 |
2023 |
Mengdie Chen, Yiyun Wang, Ping Feng, Yao Liang, Qiao Liu, Mengyao Yang, Chaoyin Lu, Penghua Shi, Jian Cheng, Anjing Ji, Qidong Zheng, Ferdinando Carlo Sasso. Association between Age at Type 2 Diabetes Onset and Diabetic Retinopathy: A Double-Center Retrospective Study, Journal of Diabetes Research. 2023; 2023: 1.
https://doi.org/10.1155/2023/5919468 |
| 7 |
2024 |
Emmanouil Korakas, Aikaterini Kountouri, George Pavlidis, Evangelos Oikonomou, Emmanouil Vrentzos, Eleni Michalopoulou, Vasiliki Tsigkou, Konstantinos Katogiannis, Loukia Pliouta, Konstantinos Balampanis, Sotirios Pililis, Konstantinos Malandris, Apostolos Tsapas, Gerasimos Siasos, Ignatios Ikonomidis, Vaia Lambadiari. Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease, Journal of the Endocrine Society. 2024; 8: bvae122.
https://doi.org/10.1210/jendso/bvae122 |
| 8 |
2024 |
Anmol Singh, Aalam Sohal, Akash Batta. GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis, World Journal of Gastroenterology. 2024; 30: 5205.
https://doi.org/10.3748/wjg.v30.i48.5205 |
| 9 |
2024 |
Emmanuel Ekpor, Samuel Akyirem, Precious Adade Duodu, Bert B. Little. Prevalence of metabolic dysfunction-associated fatty liver disease and its association with glycemic control in persons with type 2 diabetes in Africa: A systematic review and meta-analysis, PLOS Global Public Health. 2024; 4: e0002835.
https://doi.org/10.1371/journal.pgph.0002835 |
| 10 |
2023 |
Alfredo Caturano, Gaetana Albanese, Anna Di Martino, Carmine Coppola, Vincenzo Russo, Raffaele Galiero, Luca Rinaldi, Marcellino Monda, Raffaele Marfella, Ferdinando Carlo Sasso, Teresa Salvatore. Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study, Biomedicines. 2023; 11: 2866.
https://doi.org/10.3390/biomedicines11102866 |
| 11 |
2021 |
Mojtaba Malek, Mohammad E. Khamseh, Haleh Chehrehgosha, Sohrab Nobarani, Fariba Alaei-Shahmiri. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus, Endocrine. 2021; 74: 538.
https://doi.org/10.1007/s12020-021-02815-w |
| 12 |
2024 |
Faezeh Mashhadi, Nayere Khadem Ghaebi, Fatemeh Roudi, Mohsen Nematy. Metabolic and Inflammatory Profiles Across Infertile PCOS Phenotypes: Implications for Clinical Practice, The Journal of Obstetrics and Gynecology of India. 2024;
https://doi.org/10.1007/s13224-024-01997-3 |
| 13 |
2023 |
Riccardo Nevola, Raffaella Epifani, Simona Imbriani, Giovanni Tortorella, Concetta Aprea, Raffaele Galiero, Luca Rinaldi, Raffaele Marfella, Ferdinando Carlo Sasso. GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives, International Journal of Molecular Sciences. 2023; 24: 1703.
https://doi.org/10.3390/ijms24021703 |
| 14 |
2022 |
Francisco Lopez-Jimenez, Wael Almahmeed, Harold Bays, Ada Cuevas, Emanuele Di Angelantonio, Carel W le Roux, Naveed Sattar, Marie Chan Sun, Gary Wittert, Fausto J Pinto, John P H Wilding. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation, European Journal of Preventive Cardiology. 2022; 29: 2218.
https://doi.org/10.1093/eurjpc/zwac187 |
| 15 |
2024 |
Sultan Alfawaz, Abdulhadi Burzangi , Ahmed Esmat. Mechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review, Cureus. 2024;
https://doi.org/10.7759/cureus.67080 |
| 16 |
2022 |
Luotao Lin, Fengqing Zhu, Edward J. Delp, Heather A. Eicher-Miller. Differences in Dietary Intake Exist among U.S. Adults by Diabetic Status Using NHANES 2009–2016, Nutrients. 2022; 14: 3284.
https://doi.org/10.3390/nu14163284 |
| 17 |
2022 |
Agostino Milluzzo, Lucia Manuella, Laura Sciacca. Semaglutide: a game changer for metabolic diseases?, Exploration of Medicine. 2022; 173.
https://doi.org/10.37349/emed.2022.00083 |
| 18 |
2022 |
Jianan Hao, Yichao Wang, Lijing Huo, Tiantian Sun, Yunfeng Zhen, Zhe Gao, Shuchun Chen, Luping Ren. Circulating Bone Morphogenetic Protein-9 is Decreased in Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease, International Journal of General Medicine. 2022; Volume 15: 8539.
https://doi.org/10.2147/IJGM.S385513 |
| 19 |
2023 |
Alfredo Caturano, Raffaele Galiero, Giuseppe Loffredo, Erica Vetrano, Giulia Medicamento, Carlo Acierno, Luca Rinaldi, Aldo Marrone, Teresa Salvatore, Marcellino Monda, Celestino Sardu, Raffaele Marfella, Ferdinando Carlo Sasso. Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study, Biomedicines. 2023; 11: 322.
https://doi.org/10.3390/biomedicines11020322 |
| 20 |
2023 |
Ayed A. Shati, Amro Maarouf, Amal F. Dawood, Nervana M. Bayoumy, Youssef A. Alqahtani, Refaat A. Eid, Saeed M. Alqahtani, Mohamed Abd Ellatif, Bahjat Al-Ani, Alia Albawardi. Lower Extremity Arterial Disease in Type 2 Diabetes Mellitus: Metformin Inhibits Femoral Artery Ultrastructural Alterations as well as Vascular Tissue Levels of AGEs/ET-1 Axis-Mediated Inflammation and Modulation of Vascular iNOS and eNOS Expression, Biomedicines. 2023; 11: 361.
https://doi.org/10.3390/biomedicines11020361 |
| 21 |
2023 |
Erica Vetrano, Luca Rinaldi, Andrea Mormone, Chiara Giorgione, Raffaele Galiero, Alfredo Caturano, Riccardo Nevola, Raffaele Marfella, Ferdinando Carlo Sasso. Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies, Biomedicines. 2023; 11: 468.
https://doi.org/10.3390/biomedicines11020468 |
| 22 |
2021 |
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Maria Vittoria Morone, Chiara Silvestri, Mauro Giordano, Teresa Salvatore, Ferdinando Carlo Sasso. Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review, Antioxidants. 2021; 10: 270.
https://doi.org/10.3390/antiox10020270 |
| 23 |
2022 |
Vicente Aleixandre Benites-Zapata, Sofía Lorena Bohórquez-Medina, Andrea Lisbet Bohórquez-Medina. 2022; 1.
https://doi.org/10.1007/978-3-030-81303-1_9-1 |
| 24 |
2022 |
Lars Lind, Johan Sundström, Sölve Elmståhl, Koen F. Dekkers, J. Gustav Smith, Gunnar Engström, Tove Fall, Johan Ärnlöv, Ferdinando Carlo Sasso. The metabolomic profile associated with clustering of cardiovascular risk factors—A multi-sample evaluation, PLOS ONE. 2022; 17: e0274701.
https://doi.org/10.1371/journal.pone.0274701 |
| 25 |
2023 |
Vicente Aleixandre Benites-Zapata, Sofía Lorena Bohórquez-Medina, Andrea Lisbet Bohórquez-Medina. 2023; 195.
https://doi.org/10.1007/978-3-031-08014-2_9 |
| 26 |
2022 |
Sara De Nucci, Fabio Castellana, Roberta Zupo, Luisa Lampignano, Martina Di Chito, Roberta Rinaldi, Vito Giannuzzi, Raffaele Cozzolongo, Giuseppina Piazzolla, Gianluigi Giannelli, Rodolfo Sardone, Giovanni De Pergola. Associations between serum biomarkers and non-alcoholic liver disease: Results of a clinical study of Mediterranean patients with obesity, Frontiers in Nutrition. 2022; 9: 1002669.
https://doi.org/10.3389/fnut.2022.1002669 |
| 27 |
2022 |
Zengzhe Zhu, Ningning Yang, Hongmei Fu, Gang Yuan, Yong Chen, Tingting Du, Xinrong Zhou. Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement, Frontiers in Endocrinology. 2022; 13: 1002099.
https://doi.org/10.3389/fendo.2022.1002099 |
| 28 |
2023 |
In Seon Kim, Ji-Yun Hwang. Does Better Diet Quality Offset the Association between Depression and Metabolic Syndrome?, Nutrients. 2023; 15: 1060.
https://doi.org/10.3390/nu15041060 |
| 29 |
2022 |
Cosmina-Theodora Diaconu, Cristian Guja. Nonalcoholic Fatty Liver Disease and Its Complex Relation with Type 2 Diabetes Mellitus—From Prevalence to Diagnostic Approach and Treatment Strategies, Journal of Clinical Medicine. 2022; 11: 5144.
https://doi.org/10.3390/jcm11175144 |
| 30 |
2023 |
Francesco Cosentino, Subodh Verma, Philip Ambery, Marianne Bach Treppendahl, Martin van Eickels, Stefan D Anker, Michele Cecchini, Paola Fioretto, Per-Henrik Groop, David Hess, Kamlesh Khunti, Carolyn S P Lam, Isabelle Richard-Lordereau, Lars H Lund, Paul McGreavy, Philip N Newsome, Naveed Sattar, Scott Solomon, Franz Weidinger, Faiez Zannad, Andreas Zeiher. Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table, European Heart Journal. 2023; 44: 4141.
https://doi.org/10.1093/eurheartj/ehad445 |
| 31 |
2024 |
Shifat-E Ferdous, Jessica M. Ferrell. Pathophysiological Relationship between Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Therapeutic Approaches, International Journal of Molecular Sciences. 2024; 25: 8731.
https://doi.org/10.3390/ijms25168731 |
| 32 |
2023 |
Jiayuan Zhang, Xiaoling Zang, Jinxiao Lv, Yicong Zhang, Zhihua Lv, Mingming Yu. Changes in Lipidomics, Metabolomics, and the Gut Microbiota in CDAA-Induced NAFLD Mice after Polyene Phosphatidylcholine Treatment, International Journal of Molecular Sciences. 2023; 24: 1502.
https://doi.org/10.3390/ijms24021502 |
| 33 |
2022 |
Celeste M. Lavallee, Andreina Bruno, Christopher Ma, Maitreyi Raman. The Role of Intermittent Fasting in the Management of Nonalcoholic Fatty Liver Disease: A Narrative Review, Nutrients. 2022; 14: 4655.
https://doi.org/10.3390/nu14214655 |
| 34 |
2022 |
Wencong Guo, Yancheng Song, Yan Sun, Huasheng Du, Yan Cai, Qingqing You, Haixia Fu, Leping Shao. Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018, Frontiers in Endocrinology. 2022; 13: 1071465.
https://doi.org/10.3389/fendo.2022.1071465 |
| 35 |
2023 |
Riccardo Nevola, Livio Criscuolo, Domenico Beccia, Augusto Delle Femine, Rachele Ruocco, Simona Imbriani, Maria Alfano, Angela Villani, Antonio Russo, Pasquale Perillo, Raffaele Marfella, Luigi Elio Adinolfi, Ferdinando Carlo Sasso, Aldo Marrone, Luca Rinaldi. Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination, World Journal of Gastroenterology. 2023; 29: 800.
https://doi.org/10.3748/wjg.v29.i5.800 |
| 36 |
2023 |
Ramin Malboosbaf, Neda Hatami. 2023; 1.
https://doi.org/10.2174/9789815196535123010004 |
| 37 |
2021 |
Raffaele Galiero, Alfredo Caturano, Erica Vetrano, Arturo Cesaro, Luca Rinaldi, Teresa Salvatore, Raffaele Marfella, Celestino Sardu, Elisabetta Moscarella, Felice Gragnano, Paolo Calabrò, Ferdinando Carlo Sasso. Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease, Reviews in Cardiovascular Medicine. 2021; 22: 755.
https://doi.org/10.31083/j.rcm2203082 |
| 38 |
2023 |
Yun Seo Jang, Hye Jin Joo, Yu Shin Park, Eun-Cheol Park, Sung-In Jang. Association between smoking cessation and non-alcoholic fatty liver disease using NAFLD liver fat score, Frontiers in Public Health. 2023; 11: 1015919.
https://doi.org/10.3389/fpubh.2023.1015919 |
| 39 |
2023 |
Riccardo Nevola, Angela Villani, Simona Imbriani, Maria Alfano, Livio Criscuolo, Domenico Beccia, Rachele Ruocco, Augusto Delle Femine, Felice Gragnano, Domenico Cozzolino, Raffaele Marfella, Luigi Elio Adinolfi, Ferdinando Carlo Sasso, Luca Rinaldi. Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives, Frontiers in Bioscience-Landmark. 2023; 28: 103.
https://doi.org/10.31083/j.fbl2805103 |
| 40 |
2022 |
Jie Feng, Kun Jin, Xiaomeng Dong, Shi Qiu, Xianglong Han, Yerong Yu, Ding Bai. Association of Diet-Related Systemic Inflammation with Periodontitis and Tooth Loss: The Interaction Effect of Diabetes, Nutrients. 2022; 14: 4118.
https://doi.org/10.3390/nu14194118 |
| 41 |
2022 |
Hykoush A. Asaturyan, Nicolas Basty, Marjola Thanaj, Brandon Whitcher, E. Louise Thomas, Jimmy D. Bell, Ferdinando Carlo Sasso. Improving the accuracy of fatty liver index to reflect liver fat content with predictive regression modelling, PLOS ONE. 2022; 17: e0273171.
https://doi.org/10.1371/journal.pone.0273171 |
| 42 |
2021 |
Alfredo Caturano, Carlo Acierno, Riccardo Nevola, Pia Clara Pafundi, Raffaele Galiero, Luca Rinaldi, Teresa Salvatore, Luigi Elio Adinolfi, Ferdinando Carlo Sasso. Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact, Processes. 2021; 9: 135.
https://doi.org/10.3390/pr9010135 |
| 43 |
2022 |
Syeda Hoorulain Ahmed, Abdul Moeed, Eisha Waqar, Sahar Rizwan, Nimra Hasnain, Mohammad Aadil Qamar, Kaneez Fatima, Abdul Mannan Khan Minhas. Efficacy of sodium-glucose co-transporter 2 inhibitors in treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis, Obesity Medicine. 2022; 33: 100437100437.
https://doi.org/10.1016/j.obmed.2022.100437 |
| 44 |
2022 |
Supakit Chaipoot, Wanisa Punfa, Sakaewan Ounjaijean, Rewat Phongphisutthinant, Kanokwan Kulprachakarn, Wason Parklak, Laddawan Phaworn, Pattrawan Rotphet, Kongsak Boonyapranai. Antioxidant, Anti-Diabetic, Anti-Obesity, and Antihypertensive Properties of Protein Hydrolysate and Peptide Fractions from Black Sesame Cake, Molecules. 2022; 28: 211.
https://doi.org/10.3390/molecules28010211 |
| 45 |
2023 |
Riccardo Nevola, Giovanni Tortorella, Valerio Rosato, Luca Rinaldi, Simona Imbriani, Pasquale Perillo, Davide Mastrocinque, Marco La Montagna, Antonio Russo, Giovanni Di Lorenzo, Maria Alfano, Maria Rocco, Carmen Ricozzi, Klodian Gjeloshi, Ferdinando Carlo Sasso, Raffaele Marfella, Aldo Marrone, Loreta Anesti Kondili, Nicolino Esposito, Ernesto Claar, Domenico Cozzolino. Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma, Biology. 2023; 12: 984.
https://doi.org/10.3390/biology12070984 |
| 46 |
2022 |
Changchun Cao, Xiaohua Zhang, Junhu Yuan, Yibing Zan, Xin Zhang, Chao Xue, Yulong Wang, Xiaodan Zheng. Nonlinear relationship between aspartate aminotransferase to alanine aminotransferase ratio and the risk of prediabetes: A retrospective study based on chinese adults, Frontiers in Endocrinology. 2022; 13: 1041616.
https://doi.org/10.3389/fendo.2022.1041616 |
